A recent study indicates that individuals who stop using new GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt traditional lifestyle regimens.
Research printed in a leading health publication demonstrates that while obese people often shed about a fifth of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying such treatments need to be aware of the danger of rapid rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment mass within about a year and a half.
Analyzing Treatments
The research, which looked at 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with older methods.
Scientists note that people who shed pounds through diet and exercise usually see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Nutrition scientists suggest the way of the injections accounts for the heightened rebound.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Stopping of this medication leads to appetite is no longer kept in check, making overeating far more likely."
A Chronic Disease?
The NHS recommend the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the likelihood of relapse, the treatment is often life-long.
This view is supported by drug manufacturers, who state that the findings "highlight the chronic nature of excess weight," comparing it to managing conditions like hypertension.
User Experiences
Users who have stopped the jabs explain a powerful return of appetite.
"It was like a switch that goes on and you're instantly ravenous," said a patient.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit modifications during treatment.
Growing Use
Survey data indicate that millions of people in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while the jabs are potent tools for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on integrated lifestyle support.
